Cargando…

Clinical Utility of the Cardiorespiratory Optimal Point in Patients with Heart Failure

INTRODUCTION: We assessed the cardiorespiratory optimal point (COP)—the minimal V̇(E)/V̇O(2) in a given minute of an incremental cardiopulmonary exercise test—in patients with heart failure (HF) and aimed to determine 1) its association with patient and disease characteristics, 2) changes after an e...

Descripción completa

Detalles Bibliográficos
Autores principales: KROESEN, SOPHIE H., BAKKER, ESMÉE A., SNOEK, JOHAN A., VAN KIMMENADE, ROLAND R. J., MOLINGER, JEROEN, ARAÚJO, CLAUDIO G., HOPMAN, MARIA T. E., EIJSVOGELS, THIJS M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487388/
https://www.ncbi.nlm.nih.gov/pubmed/37192340
http://dx.doi.org/10.1249/MSS.0000000000003206
_version_ 1785103227187888128
author KROESEN, SOPHIE H.
BAKKER, ESMÉE A.
SNOEK, JOHAN A.
VAN KIMMENADE, ROLAND R. J.
MOLINGER, JEROEN
ARAÚJO, CLAUDIO G.
HOPMAN, MARIA T. E.
EIJSVOGELS, THIJS M. H.
author_facet KROESEN, SOPHIE H.
BAKKER, ESMÉE A.
SNOEK, JOHAN A.
VAN KIMMENADE, ROLAND R. J.
MOLINGER, JEROEN
ARAÚJO, CLAUDIO G.
HOPMAN, MARIA T. E.
EIJSVOGELS, THIJS M. H.
author_sort KROESEN, SOPHIE H.
collection PubMed
description INTRODUCTION: We assessed the cardiorespiratory optimal point (COP)—the minimal V̇(E)/V̇O(2) in a given minute of an incremental cardiopulmonary exercise test—in patients with heart failure (HF) and aimed to determine 1) its association with patient and disease characteristics, 2) changes after an exercise-based cardiac rehabilitation program (CR), and 3) the association with clinical outcomes. METHODS: We studied 277 HF patients (67 (58–74) yr, 30% female, 72% HF with restricted ejection fraction) between 2009 and 2018. Patients participated in a 12- to 24-wk CR program, and COP was assessed pre- and post-CR. Patient and disease characteristics and clinical outcomes (mortality and cardiovascular-related hospitalization) were extracted from patient files. The incidence of clinical outcomes was compared across COP tertiles (low, <26.0; moderate, 26.0–30.7; high, >30.7). RESULTS: Median COP was 28.2 (24.9–32.1) and was reached at 51% ± 15% of V̇O(2peak). Lower age, female sex, higher body mass index, the absence of a pacemaker or the absence of chronic obstructive pulmonary disease, and lower N-terminal prohormone brain natriuretic peptide concentrations were associated with a lower COP. Participation in CR reduced COP (−0.8; 95% confidence interval, −1.3 to −0.3). Low COP had a reduced risk (adjusted hazard ratio, 0.53; 95% confidence interval, 0.33–0.84) for adverse clinical outcomes as compared with high COP. CONCLUSIONS: Classic cardiovascular risk factors are associated with a higher, more unfavorable, COP. CR-based exercise training reduces COP, whereas a lower COP is associated with a better clinical prognosis. As COP can be established during a submaximal exercise test, this may offer novel risk stratification possibilities for HF care programs.
format Online
Article
Text
id pubmed-10487388
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104873882023-09-09 Clinical Utility of the Cardiorespiratory Optimal Point in Patients with Heart Failure KROESEN, SOPHIE H. BAKKER, ESMÉE A. SNOEK, JOHAN A. VAN KIMMENADE, ROLAND R. J. MOLINGER, JEROEN ARAÚJO, CLAUDIO G. HOPMAN, MARIA T. E. EIJSVOGELS, THIJS M. H. Med Sci Sports Exerc Clinical Sciences INTRODUCTION: We assessed the cardiorespiratory optimal point (COP)—the minimal V̇(E)/V̇O(2) in a given minute of an incremental cardiopulmonary exercise test—in patients with heart failure (HF) and aimed to determine 1) its association with patient and disease characteristics, 2) changes after an exercise-based cardiac rehabilitation program (CR), and 3) the association with clinical outcomes. METHODS: We studied 277 HF patients (67 (58–74) yr, 30% female, 72% HF with restricted ejection fraction) between 2009 and 2018. Patients participated in a 12- to 24-wk CR program, and COP was assessed pre- and post-CR. Patient and disease characteristics and clinical outcomes (mortality and cardiovascular-related hospitalization) were extracted from patient files. The incidence of clinical outcomes was compared across COP tertiles (low, <26.0; moderate, 26.0–30.7; high, >30.7). RESULTS: Median COP was 28.2 (24.9–32.1) and was reached at 51% ± 15% of V̇O(2peak). Lower age, female sex, higher body mass index, the absence of a pacemaker or the absence of chronic obstructive pulmonary disease, and lower N-terminal prohormone brain natriuretic peptide concentrations were associated with a lower COP. Participation in CR reduced COP (−0.8; 95% confidence interval, −1.3 to −0.3). Low COP had a reduced risk (adjusted hazard ratio, 0.53; 95% confidence interval, 0.33–0.84) for adverse clinical outcomes as compared with high COP. CONCLUSIONS: Classic cardiovascular risk factors are associated with a higher, more unfavorable, COP. CR-based exercise training reduces COP, whereas a lower COP is associated with a better clinical prognosis. As COP can be established during a submaximal exercise test, this may offer novel risk stratification possibilities for HF care programs. Lippincott Williams & Wilkins 2023-10 2023-05-13 /pmc/articles/PMC10487388/ /pubmed/37192340 http://dx.doi.org/10.1249/MSS.0000000000003206 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Sports Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Sciences
KROESEN, SOPHIE H.
BAKKER, ESMÉE A.
SNOEK, JOHAN A.
VAN KIMMENADE, ROLAND R. J.
MOLINGER, JEROEN
ARAÚJO, CLAUDIO G.
HOPMAN, MARIA T. E.
EIJSVOGELS, THIJS M. H.
Clinical Utility of the Cardiorespiratory Optimal Point in Patients with Heart Failure
title Clinical Utility of the Cardiorespiratory Optimal Point in Patients with Heart Failure
title_full Clinical Utility of the Cardiorespiratory Optimal Point in Patients with Heart Failure
title_fullStr Clinical Utility of the Cardiorespiratory Optimal Point in Patients with Heart Failure
title_full_unstemmed Clinical Utility of the Cardiorespiratory Optimal Point in Patients with Heart Failure
title_short Clinical Utility of the Cardiorespiratory Optimal Point in Patients with Heart Failure
title_sort clinical utility of the cardiorespiratory optimal point in patients with heart failure
topic Clinical Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487388/
https://www.ncbi.nlm.nih.gov/pubmed/37192340
http://dx.doi.org/10.1249/MSS.0000000000003206
work_keys_str_mv AT kroesensophieh clinicalutilityofthecardiorespiratoryoptimalpointinpatientswithheartfailure
AT bakkeresmeea clinicalutilityofthecardiorespiratoryoptimalpointinpatientswithheartfailure
AT snoekjohana clinicalutilityofthecardiorespiratoryoptimalpointinpatientswithheartfailure
AT vankimmenaderolandrj clinicalutilityofthecardiorespiratoryoptimalpointinpatientswithheartfailure
AT molingerjeroen clinicalutilityofthecardiorespiratoryoptimalpointinpatientswithheartfailure
AT araujoclaudiog clinicalutilityofthecardiorespiratoryoptimalpointinpatientswithheartfailure
AT hopmanmariate clinicalutilityofthecardiorespiratoryoptimalpointinpatientswithheartfailure
AT eijsvogelsthijsmh clinicalutilityofthecardiorespiratoryoptimalpointinpatientswithheartfailure